Monitor for potential strategic shifts given Febbo's capital markets background and experience scaling healthcare tech firms, which could influence future financing, partnerships, or growth initiatives. However, no immediate financial impact is expected from this board appointment.
Price Chart
Executive Summary
Myomo, Inc. appointed William J. Febbo to its Board of Directors effective April 14, 2026. Febbo, a seasoned healthcare and capital markets executive, brings significant experience from leadership roles at OptimizeRx and other firms. The appointment was disclosed via an 8-K filing and a press release.
Key Facts
- William J. Febbo was appointed to Myomo's Board of Directors effective April 14, 2026.
- Febbo is a former CEO of OptimizeRx (NASDAQ: OPRX), where revenue grew from $5M to $92M under his leadership.
- He received an initial grant of 45,000 RSUs vesting on the one-year anniversary, plus an annual $85,000 RSU retainer and $60,000 cash retainer.
- Febbo has expertise in healthcare technology, capital markets, and scaling innovative companies.
- The board now has six members following this appointment.
Financial Impact
Approximately $427,500 in annual director compensation (based on $85,000 RSUs + $60,000 cash + $45,000 initial grant amortized annually), subject to stock price fluctuations.
Risk Factors
- Limited immediate operational impact as Febbo is a non-executive director.
- Potential share dilution from RSU grants, though at current market cap the impact is minimal.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-159060 |
| Document: myo-ex99_1.htm | 0001193125-26-159060 |
| Document: 0001193125-26-159060-index-headers.html | 0001193125-26-159060 |
| Document: 0001193125-26-159060-index.html | 0001193125-26-159060 |
| Document: 0001193125-26-159060.txt | 0001193125-26-159060 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 14d ago | 144 | $1.29 | awaiting T+60 | — | $1.17 (−9.30%) |
Jun 26, 2026 17w ago | 8-K | $1.11 $1.64 | ▲ +47.75% | ▲ +43.36% | $1.17 (+5.41%) |
Jun 1, 2026 21w ago | Insider Cluster | $1.16 $1.48 | ▲ +27.59% | ▲ +26.35% | $1.17 (+0.86%) |
May 18, 2026 23w ago | Insider Cluster | $0.8780 $1.46 | ▲ +66.29% | ▲ +60.00% | $1.17 (+33.26%) |
Apr 16, 2026 27w ago | 8-K | $0.8590 $1.10 | ▲ +28.06% | ▲ +21.91% | $1.17 (+36.20%) |
Apr 13, 2026 28w ago | 144 | $0.7920 $1.16 | ▲ +46.46% | ▲ +37.94% | $1.17 (+47.73%) |
Mar 12, 2026 32w ago | Insider Cluster | $0.6967 $1.31 | ▲ +88.03% | ▲ +76.74% | $1.17 (+67.93%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers